ROCKET PHARMACEUTICALS, INC. Annual Operating Income (Loss) in USD from 2014 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Rocket Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2024.
  • Rocket Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2025 was -$71.1M, a 3.48% increase year-over-year.
  • Rocket Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2025 was -$268M, a 0.79% increase year-over-year.
  • Rocket Pharmaceuticals, Inc. annual Operating Income (Loss) for 2024 was -$273M, a 5.22% decline from 2023.
  • Rocket Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$260M, a 15.7% decline from 2022.
  • Rocket Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$224M, a 34.1% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$273M -$13.5M -5.22% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 -$260M -$35.3M -15.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 -$224M -$57.1M -34.1% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 -$167M -$32.9M -24.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 -$134M -$58.2M -76.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$76.2M -$5M -7.02% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$71.2M -$51.4M -260% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$19.8M -$12.2M -161% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-08
2016 -$7.57M +$12.8M +62.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-08
2015 -$20.4M -$12.7M -165% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-16
2014 -$7.7M Jan 1, 2014 Dec 31, 2014 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.